Mixed Rhinitis

  • Chandra Vethody
  • Jonathan A. BernsteinEmail author


Diagnosis of mixed rhinitis requires a careful history to elicit inciting triggers and diagnostic testing to assess the patient’s allergic status. These patients have sensitizations that account for some but not all of their clinical symptoms. Typically, they also notice increased congestion, drainage with or without sinus pressure/headaches, and ear popping/plugging in response to chemicals, odorants, and changing or extreme weather conditions. Incomplete treatment response to medications designed to treat allergic rhinitis is an important clinical clue that a more complex form of chronic rhinitis exists. Successful treatment of mixed rhinitis first requires recognition that there is a nonallergic component associated with allergic rhinitis. Once this is determined, tailoring treatment using a wide range of medications is required based on the patient’s tolerance of medications that address congestion and drainage will reduce the severity of symptoms, onset of comorbidities like sinusitis, and medical costs. These cases require ongoing medication management to ensure optimum clinical outcomes.


Mixed rhinitis Nasal congestion Postnasal drainage Nonallergic triggers Allergy rhinitis Irritant index questionnaire Chemicals Odorants Irritants 


  1. 1.
    Rezvani M, Brandt D, Bernstein JA, Hastings L, Willwerth J. Investigation of olfactory threshold responses in chronic rhinitis subtypes. Ann Allergy Asthma Immunol. 2007;99(6):571–2.CrossRefGoogle Scholar
  2. 2.
    Bernstein JA, Singh U. Neural abnormalities in nonallergic rhinitis. Curr Allergy Asthma Rep. 2015;15(4):18.CrossRefGoogle Scholar
  3. 3.
    Singh U, Bernstein JA, Haar L, Luther K, Jones WK. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Am J Rhinol Allergy. 2014;28(3):215–24.CrossRefGoogle Scholar
  4. 4.
    Brandt D, Bernstein JA. Questionnaire diagnosis of nonallergic rhinitis. Clin Allergy Immunol. 2007;19:55–67.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Bernstein JA, Rezvani M. Mixed rhinitis: a new subclass of chronic rhinitis? In: Kaliner M, editor. Curent review of rhinitis. 2nd ed. Philadelphia: Current Medicine; 2006. p. 69–78.Google Scholar
  6. 6.
    Bernstein JA, Levin LS, Al-Shuik E, Martin VT. Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens. Ann Allergy Asthma Immunol. 2012;109(3):173–8.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Campo P, Salas M, Blanca-López N, Rondón C. Local allergic rhinitis. Immunol Allergy Clin N Am. 2016;36(2):321–32.CrossRefGoogle Scholar
  8. 8.
    Campo P, Rondón C, Gould HJ, Barrionuevo E, Gevaert P, Blanca M. Local IgE in non-allergic rhinitis. Clin Exp Allergy. 2015;45(5):872–81.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Gelardi M, Iannuzzi L, Tafuri S, Passalacqua G, Quaranta N. Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history. Acta Otorhinolaryngol Ital. 2014;34(1):36–41.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Gelardi M, Fiorella ML, Russo C, Fiorella R, Ciprandi G. Role of nasal cytology. Int J Immunopathol Pharmacol. 2010;23(1 Suppl):45–9.PubMedGoogle Scholar
  11. 11.
    Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 Suppl):S1–84.CrossRefPubMedGoogle Scholar
  12. 12.
    Stokes J. Anti-IgE treatment for disorders other than asthma. Front Med (Lausanne). 2017;4:152.CrossRefGoogle Scholar
  13. 13.
    Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Vasomotor rhinitis study, efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001;86(1):28–35.CrossRefGoogle Scholar
  14. 14.
    Singh U, Bernstein JA. Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis. Prog Drug Res. 2014;68:147–70.PubMedGoogle Scholar
  15. 15.
    Bernstein JA, Davis BP, Picard JK, Cooper JP, Zheng S, Levin LS. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011;107(2):171–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Singh U, Bernstein JA, Lorentz H, Sadoway T, Nelson V, Patel P, et al. A pilot study investigating clinical responses and biological pathways of Azelastine/fluticasone in nonallergic vasomotor rhinitis before and after cold dry air provocation. Int Arch Allergy Immunol. 2017;173(3):153–64.CrossRefGoogle Scholar
  17. 17.
    Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. Allergy Asthma Proc. 2011;32(2):151–8.CrossRefGoogle Scholar
  18. 18.
    Meltzer EO. The treatment of vasomotor rhinitis with intranasal corticosteroids. World Allergy Organ J. 2009;2(8):166–79.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Georgitis JW, Banov C, Boggs PB, Dockhorn R, Grossman J, Tinkelman D, et al. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy. 1994;24(11):1049–55.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lin L, Lu Q, Tang XY, Dai F, Wei JJ. Nasal irrigation for the treatment of vasomotor rhinitis: a pilot study. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017;52(6):446–52.PubMedGoogle Scholar
  21. 21.
    Smith AM, Rezvani M, Bernstein JA. Is response to allergen immunotherapy a good phenotypic marker for differentiating between allergic rhinitis and mixed rhinitis? Allergy Asthma Proc. 2011;32(1):49–54.CrossRefGoogle Scholar
  22. 22.
    Baroody FM, Brown D, Gavanescu L, DeTineo M, Naclerio RM. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011;127(4):927–34.CrossRefGoogle Scholar
  23. 23.
    Meltzer EO, Bernstein DI, Prenner BM, Berger WE, Shekar T, Teper AA. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Am J Rhinol Allergy. 2013;27(2):102–8.CrossRefGoogle Scholar
  24. 24.
    Vaidyanathan S, Williamson P, Clearie K, Khan F, Lipworth B. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. Am J Respir Crit Care Med. 2010;182(1):19–24.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Internal MedicineUniversity of LouisvilleLouisvilleUSA
  2. 2.Division of Immunology, Rheumatology and Allergy, Department of Internal MedicineUniversity of CincinnatiCincinnatiUSA

Personalised recommendations